GammaTile Therapy

Perspectives

What patients are saying about GammaTile Therapy

Patient Educational Event | April 29, 2020 | Oscar, a survivor of a high-grade glioma treated with GammaTile Therapy

Minnesota CBS Patient Interview | February 14, 2019 |
 New brain cancer treatment GammaTile Therapy at University of Minnesota with survivor Linda Tinega

Ohio CBS Patient Interview | November 15, 2019 |

New brain cancer therapy provides radiation right at tumor site

Patient Experience Video | January 16, 2020 |

Oscar, a survivor of a high-grade glioma treated with GammaTile Therapy

Patient Experience Video | September 11, 2019 |

Joan, a survivor of a meningioma treated with GammaTile Therapy

Patient Experience Video | April 21, 2020 |

Shannan, a survivor of a low-grade glioma treated with GammaTile Therapy

Personal Experiences

My quality of life has been very good due to GammaTile Therapy. I’m just really thankful that GammaTile Therapy was available.

 

JOAN | MENINGIOMA TUMOR SURVIVOR

TREATMENT CONSIDERATIONS 

GammaTile Therapy is intended to deliver radiation therapy in patients with newly diagnosed malignant brain tumors and recurrent brain tumors. The potential for, and symptoms of, adverse events related to radiation exposure vary depending on the radiosensitivity of the exposed tissue, the amount of radiation delivered, and the placement of GammaTile(s). Serious side effects related to GammaTile Therapy are rare, and may include radiation brain changes including necrosis. GammaTile Therapy should not be used for patients with known history of hypersensitivity to bovine-derived materials. Possible complications can occur with any neurosurgical procedure, including cerebrospinal fluid leaks, infection, delayed hemorrhage, and adhesion formation.

CONNECT WITH US
  • Twitter
  • LinkedIn
  • Facebook
  • YouTube

©2020 GT Medical Technologies, Inc. I All rights reserved 

IMPROVING THE LIVES OF PATIENTS WITH BRAIN TUMORS